Ron Abraham Mayron

OCON Medical Ltd. engages in the research and development of intrauterine device. Its products include Intrauterine Ball IUB and IUB SCu300. The company was founded by Ilan Baram on 2008 and is headquartered in Modiin, Israel.

Oxygen & Argon Works Ltd. engages in the production and marketing of industrial gases. Its products include greenhouse air oxygen, nitrogen, argon, acetylene, compressed air, gas mixtures, specialty gases, and liquid helium. The company was founded in 1960 and is headquartered in Caesarea, Israel.

IOPtima Ltd. develops minimally-invasive surgical ophthalmic devices. The firm offers IOPtimate, a laser based surgical system to treat patients with primary open-angle glaucoma and pseudo-exfoliative glaucoma. Its IOPtimate utilizes a CO2 laser technology to reduce internal eye pressure by restoring the natural fluid percolation without penetrating into the eye. The company was founded in 2005 and is headquartered in Kiryat Atidim, Israel.

Virility Medical Ltd. engages in developing intimate skin patch for the treatment of premature ejaculation. The company was founded by Tal Gollan and is headquartered in Nazareth Elit, Israel.

Kaizen Bio Tech Ltd. develops medical products. Their products enable nursing mothers to gain a reliable indication of the amount of milk their baby is receiving. The company is headquartered in Tel Aviv, Israel.

I.R-Med Ltd. is a medical device company specializing in infrared light-based diagnostics. The company was founded by Ronnie Klein on September 27, 2012 and is headquartered in Rosh Pinna, Israel.

Simplivia Healthcare Ltd. is engaged in producing medical devices. Its products include chemfort, tevadaptor, and general sets. Then company is headquartered in Kiryat Shmona, Israel.

Part of NurExone Biologic, Inc., NurExone Biologic Ltd. is an Israeli company that offers a new approach to Spinal Cord Injury treatment. The private company is based in Bnei-Brak, Israel. The company believes that intranasal exosome administration offers an alternative to cell transplantation. The company was founded in 2020 by Yoram Nathan Drucker. Lior Shaltiel has been the CEO of the company since 2021. NurExone Biologic was acquired by EnerSpar Corp. on June 15, 2022.